SubContract Account for 3046955200 - Randomized Phase II Trail of Carboplatin and Gemcitabine with or without Dexmethasone in Patients with Untreated Stage IIIB Pleural Effusion and Stage IV Non-Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/06 → 12/31/11

Funding

  • Lily Research Laboratories: $87,046.00